期刊
BLOOD
卷 108, 期 1, 页码 134-140出版社
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2005-03-1219
关键词
-
类别
资金
- MRC [G0500707] Funding Source: UKRI
- Medical Research Council [G0500707] Funding Source: researchfish
- Medical Research Council [G0500707] Funding Source: Medline
- Wellcome Trust Funding Source: Medline
The pathophysiology of microthrombocytopenia in the Wiskott-Aldrich syndrome (WAS) and its milder form, X-linked thrombocytopenia (XLT), is unclear. Although quantitative defects are correctable by splenectomy, residual platelet abnormalities are suggestive of intrinsic disturbances of production. In contrast to human patients, murine models of WASp deficiency exhibit only mild thrombocytopenia, and platelets are of normal size. Here, we have identified a critical role for WASp during murine platelet biogenesis. By electron microscopy, WASp-deficient MKs appeared to have shed platelets ectopically within the bone marrow space. WASp-deficient megakaryocytes (MKs) also displayed defects in response to fibrillar collagen I (CI) in vitro, the major matrix component of bone. These included a loss of normal CI receptor (alpha 2 beta 1 integrin)-mediated inhibition of proplatelet formation, a marked abrogation of SDF-1-induced chemotactic migration of CD41(+) MKs adherent to Cl, and an almost complete lack of actin-rich podosomes, normally induced by interaction between Cl and its receptors GPVI or alpha 2 beta 1 integrin. These findings highlight the central and highly specialized role of WASp in MKs during platelet biogenesis, and may provide a mechanism for the mild thrombocytopenia observed in WASp-deficient mice. In addition, they suggest a novel explanation for some of the platelet abnormalities characteristic of patients with WAS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据